Showing 901 - 920 results of 18,335 for search 'significantly ((((step decrease) OR (((a decrease) OR (nn decrease))))) OR (observed decrease))', query time: 0.81s Refine Results
  1. 901

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  2. 902

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  3. 903

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  4. 904
  5. 905
  6. 906
  7. 907
  8. 908
  9. 909
  10. 910
  11. 911
  12. 912
  13. 913
  14. 914
  15. 915
  16. 916
  17. 917
  18. 918
  19. 919

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    “…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …”
  20. 920

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    “…Among the letrozole-treated patients, the mean FIB-4 index tended to decline during letrozole treatment; a significant decrease was observed at 18 and 24 months compared with the baseline values (p = 0.044 and p = 0.013). …”